We herewith a press release titled Extract of Audited Standalone and Consolidated financial Results of the Quarter and Year Ended March''31,2026 for your kind information and record.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Asarfi Hospital Limited reported strong FY26 results with revenue growing 42% YoY to ₹117.3 Crore. The company achieved an EBITDA margin of 20% and PAT margin of 10%, driven by improved ARPOB, better realizations and enhanced case mix. Operational performance showed robust momentum with IPD revenue growing 45% YoY and OPD revenue increasing 14% YoY. The growth was supported by high-acuity specialties like Cardiology, Neurosciences and Orthopaedics, along with improved traction in Radiation Oncology at the cancer unit. The audited results were reviewed by the Audit Committee and approved by the Board of Directors on May 11, 2026.
The 42% revenue growth and stable 10% PAT margin indicate strong operational leverage and execution capability, which should be viewed positively by investors. The growth in high-acuity specialties and ARPOB suggests improving quality of earnings and hospital bed utilization.